SMTL ID : 9eza.1

Interleukin-31 Receptor D1D2 in complex with Nemolizumab derived scFv

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

hetero-2-2-mer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 8 residues within 4Å: Chain C: Y.71 Chain D: Y.32, K.35, N.36, T.38, S.81, F.83, K.120 No protein-ligand interaction detected (PLIP)

4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 7 residues within 4Å: Chain A: Y.71 Chain B: Y.32, K.35, N.36, T.38, S.81, F.83 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:Y.71, B:N.36 NAG.3: 3 residues within 4Å: Chain B: F.60, N.92, R.114 2 PLIP interactions: 2 interactions with chain B Hydrophobic interactions: B:F.60 Hydrogen bonds: B:N.92 NAG.4: 3 residues within 4Å: Chain D: F.60, N.92, R.114 1 PLIP interactions: 1 interactions with chain D Hydrogen bonds: D:N.92 NAG.5: 3 residues within 4Å: Chain D: E.25, N.26, S.42 3 PLIP interactions: 3 interactions with chain D Hydrogen bonds: D:E.25, D:N.26, D:S.42

1 x 01: BES buffer

01.6: 7 residues within 4Å: Chain D: T.111, Y.112, W.113, R.114, N.117, I.118, K.208 3 PLIP interactions: 3 interactions with chain D Hydrogen bonds: D:R.114, D:N.117 Salt bridges: D:K.208

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bloch, Y. et al., Structural basis of the Interleukin-31 signaling complex and its inhibition. To Be Published

Release Date

2025-07-16

Peptides

Nemolizumab scFv: AC
Interleukin-31 receptor subunit alpha: BD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

B
B

D
D

Nemolizumab scFv

Interleukin-31 receptor subunit alpha